Philippa C. Matthews

18.2k total citations · 1 hit paper
141 papers, 4.1k citations indexed

About

Philippa C. Matthews is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Philippa C. Matthews has authored 141 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Epidemiology, 57 papers in Hepatology and 51 papers in Infectious Diseases. Recurrent topics in Philippa C. Matthews's work include Hepatitis B Virus Studies (69 papers), Hepatitis C virus research (54 papers) and Liver Disease Diagnosis and Treatment (34 papers). Philippa C. Matthews is often cited by papers focused on Hepatitis B Virus Studies (69 papers), Hepatitis C virus research (54 papers) and Liver Disease Diagnosis and Treatment (34 papers). Philippa C. Matthews collaborates with scholars based in United Kingdom, South Africa and United States. Philippa C. Matthews's co-authors include Philip Goulder, Anna McNaughton, Paul Klenerman, Ivor Byren, Anthony R. Berendt, Bruce D. Walker, Derrick W. Crook, Nicole Stoesser, Anna María Geretti and Jonathan M. Carlson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Philippa C. Matthews

136 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

2021 330 citations Koen B. Pouwels, Emma Pritchard et al. profile →

Peers

Philippa C. Matthews

EPIDE

VIROL

HEPAT

IMMUN

Odile Launay France

Tomàs Pumarola Spain

Joseph Torresi Australia

Punnee Pitisuttithum Thailand

Andrea Gori Italy

Roger Y. Dodd United States

Joshua T. Schiffer United States

Gilles Pialoux France

Leo G. Visser Netherlands

Sandra S. Chaves United States

Odile Launay France

Philippa C. Matthews

2.6k ×1.6

3.3k ×2.1

EPIDE

666 ×0.6

VIROL

504 ×0.5

HEPAT

810 ×1.0

IMMUN

Citations per year, relative to Philippa C. Matthews Philippa C. Matthews (= 1×) peers Odile Launay

Countries citing papers authored by Philippa C. Matthews

Since Specialization

Citations

This map shows the geographic impact of Philippa C. Matthews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippa C. Matthews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippa C. Matthews more than expected).

Fields of papers citing papers by Philippa C. Matthews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippa C. Matthews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippa C. Matthews. The network helps show where Philippa C. Matthews may publish in the future.

Co-authorship network of co-authors of Philippa C. Matthews

This figure shows the co-authorship network connecting the top 25 collaborators of Philippa C. Matthews. A scholar is included among the top collaborators of Philippa C. Matthews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippa C. Matthews. Philippa C. Matthews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yifan, Eneyi E. Kpokiri, Ye Zhang, et al.. (2025). Community engagement and chronic viral hepatitis public health interventions: a systematic review, meta-analysis, and complementary crowdsourcing open call. EClinicalMedicine. 83. 103234–103234.

Byott, Matthew, Paul R. Grant, Clare Booth, et al.. (2025). Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice. Clinical Infectious Diseases.

Pritchard, Emma, Karina-Doris Vihta, David W. Eyre, et al.. (2024). Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar. American Journal of Epidemiology. 193(12). 1848–1860. 1 indexed citations

Easterbrook, Philippa, Nathan Ford, William L. Irving, et al.. (2024). Prevalence of Drug Resistance Associated Substitutions in Persons With Chronic Hepatitis C Infection and Virological Failure Following Initial or Re-treatment With Pan-genotypic Direct-Acting Antivirals: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 79(6). 1437–1446. 1 indexed citations

Ng, Esther, James Michael Harris, Yanxia Wu, et al.. (2023). An enrichment protocol and analysis pipeline for long read sequencing of the hepatitis B virus transcriptome. Journal of General Virology. 104(5). 8 indexed citations

Vihta, Karina-Doris, Koen B. Pouwels, Tim Peto, et al.. (2022). Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom. Clinical Infectious Diseases. 66 indexed citations

Lourenço, José, Anna McNaughton, Caitlin Pley, et al.. (2022). Polymorphisms predicting phylogeny in hepatitis B virus. Virus Evolution. 9(1). veac116–veac116. 1 indexed citations

Matthews, Philippa C. & Anna Kramvis. (2022). Hepatitis B virus (HBV) and hepatocellular carcinoma (HCC) in sub-Saharan Africa: no room for complacency. Hepatoma Research. 8(3). 14–14. 1 indexed citations

Mokaya, Jolynne, Tetyana I. Vasylyeva, Eleanor Barnes, et al.. (2021). Global prevalence and phylogeny of hepatitis B virus (HBV) drug and vaccine resistance mutations. Journal of Viral Hepatitis. 28(8). 1110–1120. 14 indexed citations

10.

Jones, Nicholas, Nia Roberts, José M Ordóñez-Mena, et al.. (2021). Risk of adverse coronavirus disease 2019 outcomes for people living with HIV. AIDS. 35(4). F1–F10. 61 indexed citations

11.

Wang, Tingyan, David A. Smith, Cori Campbell, et al.. (2021). Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019. Hepatology Communications. 5(9). 1586–1604. 6 indexed citations

12.

Chowdhury, Fazle Rabbi, Anna McNaughton, Md Robed Amin, et al.. (2021). Endemic HBV among hospital in-patients in Bangladesh, including evidence of occult infection. Journal of General Virology. 102(7). 3 indexed citations

13.

Campbell, Cori, Tingyan Wang, Anna McNaughton, Eleanor Barnes, & Philippa C. Matthews. (2020). Risk factors for the development of hepatocellular carcinoma (HCC) in chronic hepatitis B virus (HBV) infection: a systematic review and meta‐analysis. Journal of Viral Hepatitis. 28(3). 493–507. 57 indexed citations

14.

Lythgoe, Katrina, Sheila Lumley, Lorenzo Pellis, Jane A. McKeating, & Philippa C. Matthews. (2020). Estimating hepatitis B virus cccDNA persistence in chronic infection†. Virus Evolution. 7(1). veaa063–veaa063. 20 indexed citations

15.

McNaughton, Anna, Peter Revill, Margaret Littlejohn, Philippa C. Matthews, & M. Azim Ansari. (2020). Analysis of genomic-length HBV sequences to determine genotype and subgenotype reference sequences. Journal of General Virology. 101(3). 271–283. 33 indexed citations

16.

Mokaya, Jolynne, Tongai Maponga, Anna McNaughton, et al.. (2020). Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults. Journal of Clinical Virology. 129. 104548–104548. 18 indexed citations

17.

Xu, Yu, Kuiama Lewandowski, Louise Downs, et al.. (2020). Nanopore metagenomic sequencing of influenza virus directly from respiratory samples: diagnosis, drug resistance and nosocomial transmission. Eurosurveillance. 1 indexed citations

18.

Mokaya, Jolynne, Anna McNaughton, Tongai Maponga, et al.. (2018). A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review. SHILAP Revista de lepidopterología. 3. 29–29. 61 indexed citations

19.

Mokaya, Jolynne, Anna McNaughton, Tongai Maponga, et al.. (2018). A blind spot? Confronting the stigma of hepatitis B virus (HBV) infection - A systematic review. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 3. 29–29. 52 indexed citations

20.

Payne, Rebecca, Maximilian Muenchhoff, Jaclyn K. Mann, et al.. (2014). Impact of HLA-driven HIV adaptation on virulence in populations of high HIV seroprevalence. Proceedings of the National Academy of Sciences. 111(50). E5393–400. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact